Skip to content

Multiple Myeloma vs Melanoma: What is the Difference?

Published: | Updated:

Multiple myeloma and melanoma are completely different cancers that sound similar. Multiple myeloma is a blood cancer that starts in the bone marrow's plasma cells, while melanoma is a cancer that begins in the skin. They have entirely different causes, symptoms, and treatments.

Key Takeaways

  • Multiple myeloma is a blood cancer starting in the bone marrow, whereas melanoma is a skin cancer.
  • The medical names sound similar because both end in oma meaning tumor, but their prefixes describe entirely different cells.
  • Myeloma is called multiple because it simultaneously affects multiple areas of bone marrow, causing bone damage called lytic lesions.
  • Myeloma requires blood tests, bone marrow biopsies, and imaging for diagnosis, while melanoma is diagnosed via skin biopsy.
  • Multiple myeloma patients are treated by a hematologist or medical oncologist rather than a dermatologist.

Multiple myeloma and melanoma are entirely different types of cancer that are often confused because their names sound similar. Multiple myeloma is a type of blood cancer that begins in the bone marrow, specifically in white blood cells called plasma cells [1][2]. Melanoma, on the other hand, is a type of cancer that most commonly begins on the surface of the body in the skin [3]. They have entirely different causes, symptoms, and treatments.

Why Do They Sound Similar?

The confusion comes from medical terminology. Both end in the Greek suffix “-oma,” which means tumor or cancer [1]. However, the first part of the word tells you exactly what type of cell is involved:

  • “Myelo-” means marrow, referring to the bone marrow where your plasma cells live [1].
  • “Melano-” means dark or black, referring to the pigment-producing cells in the skin [3].

Why is it Called “Multiple” Myeloma?

The word “myeloma” refers to a cancer of the plasma cells in the bone marrow [1][2]. Doctors use the word “multiple” because this cancer does not usually form a single, localized lump. Instead, the abnormal plasma cells spread throughout the bone marrow and form in multiple different areas of bone across the body at the same time [4][5].

It is common for these cancer cells to gather in areas where bone marrow is most active, such as the spine, skull, hips, and ribs [4][6]. Because the cancer cells are growing in numerous places and causing systemic bone involvement, it is called multiple myeloma [4][5].

Hearing that cancer is in multiple bones can sound terrifying, but it is important to know that this widespread nature is simply how blood cancers behave. Unlike solid tumors, blood cancers are treated with systemic (body-wide) therapies that are specifically designed to target the cancer everywhere it exists [1].

How are Myeloma and Melanoma Different?

  • Where they start: Multiple myeloma begins inside your bones in the soft, spongy tissue called bone marrow [1][4]. It specifically affects plasma cells, which are part of your immune system that normally make antibodies to fight infections [1][2]. Melanoma most commonly begins in the skin, affecting melanocytes (the cells that produce pigment) [3].
  • How they grow and feel: Melanoma usually starts as a single spot or unusual mole on the skin that can be seen from the outside [3]. While it can spread to other organs if not treated, it typically originates in one localized place [7]. Multiple myeloma is a body-wide blood cancer that crowds out healthy blood cells, leading to fatigue and frequent infections [1][2]. It also spreads within the bone marrow to create areas of bone damage called lytic lesions [4][6]. These lesions are the underlying cause of the severe bone pain many multiple myeloma patients experience [1][4].
  • How they are diagnosed: A doctor diagnoses melanoma primarily by looking at the skin and taking a biopsy of a suspicious mole [8]. Multiple myeloma is diagnosed using blood tests, urine tests, bone marrow biopsies, and imaging scans (like X-rays, PET scans, or MRIs) [9]. Doctors use these tests to look for bone damage and abnormal proteins in the blood—often referred to on lab reports as an M-protein, M-spike, or light chains [1][9].

Clarifying Your Care Team

When you are newly diagnosed, the medical vocabulary can be overwhelming. Knowing exactly what type of cancer you have and where it is located is the first step in understanding your treatment options. Because multiple myeloma affects the blood and bones, you will work with a hematologist (a doctor who specializes in blood diseases) or a medical oncologist (a cancer specialist), rather than a dermatologist (skin doctor).

Frequently Asked Questions

Why do multiple myeloma and melanoma sound so similar?
Both names end in the Greek suffix oma, which means tumor or cancer. The prefix myelo refers to the bone marrow where multiple myeloma starts, while melano refers to the dark pigment cells in the skin where melanoma begins.
Why is it called multiple myeloma?
It is called multiple because the abnormal plasma cells do not form a single lump. Instead, they spread and form in multiple different areas of the bone marrow across the body at the same time, often in the spine, skull, hips, and ribs.
How is multiple myeloma diagnosed compared to melanoma?
Melanoma is typically diagnosed by examining the skin and performing a biopsy of a suspicious mole. Multiple myeloma is diagnosed using blood and urine tests, bone marrow biopsies, and imaging scans to look for bone damage and abnormal proteins.
What kind of doctor treats multiple myeloma?
Because multiple myeloma is a cancer of the blood and bones, it is treated by a hematologist or a medical oncologist. Melanoma is typically managed by a dermatologist and a medical oncologist.
What causes bone pain in multiple myeloma?
Multiple myeloma spreads within the bone marrow and creates areas of bone damage known as lytic lesions. These lesions weaken the bone and are the underlying cause of the severe bone pain many patients experience.

Questions for Your Doctor

  • What specific bones or areas of my body are currently showing signs of lytic lesions or bone damage?
  • What are my M-protein and light chain levels right now, and how will we use them to track my response to treatment?
  • What is our plan to help manage my bone pain and protect my skeleton from further damage?
  • How frequently will I need blood tests or imaging scans to monitor my condition?
  • Which symptoms (like a fever or new pain) should prompt me to call the clinic immediately?

Questions for You

  • What specific physical symptoms, like bone pain or unusual fatigue, first prompted me to seek medical care?
  • Which medical terms on my lab reports or imaging results are still confusing to me?
  • Have I set up a system or brought a loved one to help me take notes during my appointments with the hematologist?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Multiple myeloma: Every year a new standard?

    Rajkumar SV

    Hematological oncology 2019; (37 Suppl 1()):62-65 doi:10.1002/hon.2586.

    PMID: 31187526
  2. 2

    Multiple Facets of Multiple Myeloma in Kidney Biopsy: A Multicenter Retrospective Study.

    Shankar M, Anandh U, Guditi S

    Indian journal of nephrology 2024; (34(1)):31-36 doi:10.4103/ijn.ijn_362_22.

    PMID: 38645901
  3. 3

    Advances in Understanding Spontaneously Occurring Melanoma in Animals.

    Blacklock KL, van der Weyden L

    Veterinary sciences 2023; (10(3)) doi:10.3390/vetsci10030210.

    PMID: 36977249
  4. 4

    A Patient of Multiple Myeloma with Absent M-spike on Serum Protein Electrophoresis and Elevated Serum-Free Light Chains: A Case Report and Literature Review.

    Lalani A, Aziz K, Khan M, et al.

    Cureus 2019; (11(8)):e5398 doi:10.7759/cureus.5398.

    PMID: 31620322
  5. 5

    FDG PET/CT in Cutaneous Involvement of Plasmablastic Plasma Cell Myeloma.

    Mohamed P, Stuart S, Vergara-Lluri R, Colletti PM

    Clinical nuclear medicine 2025; (50(2)):e127-e129 doi:10.1097/RLU.0000000000005584.

    PMID: 39601055
  6. 6

    Unusual Extramedullary Manifestation in Multiple Myeloma: Bilateral Synchronous Testicular Infiltration.

    Strauss D, Sachpekidis C, Dapunt U, et al.

    Clinical nuclear medicine 2023; (48(2)):e76-e77 doi:10.1097/RLU.0000000000004496.

    PMID: 36399719
  7. 7

    Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.

    Kim JE, Chung BY, Sim CY, et al.

    Journal of Korean medical science 2019; (34(16)):e126 doi:10.3346/jkms.2019.34.e126.

    PMID: 31020815
  8. 8

    Dermoscopic features of neoplasms in skin of color: A review.

    Ezenwa E, Stein JA, Krueger L

    International journal of women's dermatology 2021; (7(2)):145-151 doi:10.1016/j.ijwd.2020.11.009.

    PMID: 33937480
  9. 9

    Biopsy Type Disparities in Patients With Melanoma: Who Receives the Standard of Care?

    Restrepo DJ, Huayllani MT, Boczar D, et al.

    Anticancer research 2019; (39(11)):6359-6363 doi:10.21873/anticanres.13848.

    PMID: 31704868

This page explains the differences between multiple myeloma and melanoma for educational purposes only. Always consult your hematologist or oncologist for an accurate diagnosis and medical advice.

Stay up to date

Get notified when new research about Multiple Myeloma is published.

No spam. Unsubscribe anytime.